NDC 31722-189 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate

Dextroamphetamine Saccharate 6.25 mg/1; Amphetamine Aspartate Monohydrate 6.25 mg/1; Dextroamphetamine Sulfate 6.25 mg/1; Amphetamine Sulfate 6.25 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII

Product NDC31722-189

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate
Generic name
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA214959
Marketed since
September 29, 2021
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
31722-189-01100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (31722-189-01)Sep 29, 2021

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products